HIGHLAND CAPITAL MANAGEMENT, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$26,000
+44.4%
41,0000.0%0.00%0.0%
Q2 2016$18,000
+5.9%
41,000
+156.2%
0.00%
+100.0%
Q1 2016$17,000
-79.3%
16,000
-38.5%
0.00%
-85.7%
Q3 2015$82,000
-33.9%
26,000
+23.8%
0.01%
-30.0%
Q2 2015$124,000
+5.1%
21,000
+90.9%
0.01%
-56.5%
Q1 2015$118,00011,0000.02%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders